SEAN MCCARTHY: Open Payments
NPI 1962587089 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 25 payments from 11 companies in 2025. Trend: 2023 $940 · 2024 $846 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $118 |
| Lundbeck LLC | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Alkermes, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Corium, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: REXULTI, FANAPT, COBENFY, Auvelity, ARISTADA, CAPLYTA, UZEDY, Azstarys.
Industry payments across TX — which companies pay providers there.
